Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP975493.RA7KzyzYiw389vnzmCuey5y3V0PuHDLkbOQUXAuA_cTyM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP975493.RA7KzyzYiw389vnzmCuey5y3V0PuHDLkbOQUXAuA_cTyM130_assertion type Assertion NP975493.RA7KzyzYiw389vnzmCuey5y3V0PuHDLkbOQUXAuA_cTyM130_head.
- NP975493.RA7KzyzYiw389vnzmCuey5y3V0PuHDLkbOQUXAuA_cTyM130_assertion description "[In the present study, we examined the effects of 2 IKK inhibitors, N-(1,8-Dimethylimidazo[1,2-a]quinoxalin-4-yl)-1,2-ethanediamine hydrochloride (BMS-345541) and 2-[(aminocarbonyl)amino]-5-(4-fluorophenyl)-3-thiophenecarboxamide (TPCA-1), on IFN action in several human glioma cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP975493.RA7KzyzYiw389vnzmCuey5y3V0PuHDLkbOQUXAuA_cTyM130_provenance.
- NP975493.RA7KzyzYiw389vnzmCuey5y3V0PuHDLkbOQUXAuA_cTyM130_assertion evidence source_evidence_literature NP975493.RA7KzyzYiw389vnzmCuey5y3V0PuHDLkbOQUXAuA_cTyM130_provenance.
- NP975493.RA7KzyzYiw389vnzmCuey5y3V0PuHDLkbOQUXAuA_cTyM130_assertion SIO_000772 22509977 NP975493.RA7KzyzYiw389vnzmCuey5y3V0PuHDLkbOQUXAuA_cTyM130_provenance.
- NP975493.RA7KzyzYiw389vnzmCuey5y3V0PuHDLkbOQUXAuA_cTyM130_assertion wasDerivedFrom befree-2016 NP975493.RA7KzyzYiw389vnzmCuey5y3V0PuHDLkbOQUXAuA_cTyM130_provenance.
- NP975493.RA7KzyzYiw389vnzmCuey5y3V0PuHDLkbOQUXAuA_cTyM130_assertion wasGeneratedBy ECO_0000203 NP975493.RA7KzyzYiw389vnzmCuey5y3V0PuHDLkbOQUXAuA_cTyM130_provenance.